Targeting Telomerase with GV1001 Vaccine Does Not Prolong OS in Advanced Pancreatic Cancer

Article Information

DOI 
http://dx.doi.org/10.1177/155989771306017
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2013 MD Conference Express®

Author Information

  1. Emma Hitt Nichols, PhD
  1. Gary W. Middleton, MD
    1. University of Birmingham, Birmingham, United Kingdom
View Full Text

Article usage

AbstractFullPDF
Apr 2015600
May 2015200
Jul 2015500
Aug 2015200
Sep 2015300
Oct 2015132
Nov 2015211
Total2143

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Targeting Telomerase with GV1001 Vaccine Does Not Prolong OS in Advanced Pancreatic Cancer
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Vaccinations
Gastrointestinal Cancers Clinical Trials
Oncology
Vaccinations
Gastrointestinal Cancers
Oncology Clinical Trials